Metabolic remodeling by RNA polymerase gene mutations is associated with reduced β-lactam susceptibility in oxacillin-susceptible MRSA.
Methicillin-Resistant Staphylococcus aureus
/ genetics
Oxacillin
/ pharmacology
DNA-Directed RNA Polymerases
/ genetics
Anti-Bacterial Agents
/ pharmacology
Microbial Sensitivity Tests
beta-Lactams
/ pharmacology
Bacterial Proteins
/ genetics
Mutation, Missense
Cell Wall
/ drug effects
Humans
Mutation
Metabolomics
MRSA
OS-MRSA
RNA polymerases
Staphylococcus aureus
antimicrobial resistant
beta-lactams
oxacillin
rpoBC
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
12 Jun 2024
12 Jun 2024
Historique:
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
11
7
2024
Statut:
ppublish
Résumé
The emergence of oxacillin-susceptible methicillin-resistant The emergence of oxacillin-susceptible methicillin-resistant
Identifiants
pubmed: 38988221
doi: 10.1128/mbio.00339-24
doi:
Substances chimiques
Oxacillin
UH95VD7V76
DNA-Directed RNA Polymerases
EC 2.7.7.6
Anti-Bacterial Agents
0
beta-Lactams
0
Bacterial Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0033924Subventions
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 19K08960
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 22K19386
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 20F20104
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 21K19488
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : L21543
Organisme : Takeda Science Foundation (TSF)
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP21fk0108497
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP21fk0108496
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP21wm0325022
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP22ae0121045
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP21gm1610002
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP20fk0108134
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.